Fighting Lupus

MIT's Technology Review reports on a new approach to treating lupus that could reverse the autoimmune disease's effects on the immune system. Two companies — ImmuPharma in London and Cephalon in Pennsylvania — are collaborating to develop an experimental drug called Lupuzor, which has just ended Phase II trials with some promising data, the Review's Arlene Weintraub says. Instead of shutting down the immune system the way chemotherapy does, Lupuzor targets T and B cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.